Curcumin and tumor immune-editing: resurrecting the immune system

MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu

(2015) Dewan M. S. Hossain et al.   IMMUNOLOGY

Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway

(2015) Alan Yueh-Luen Lee et al.   INTEGRATIVE CANCER THERAPIES

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways

(2014) T. Das et al.   JOURNAL OF IMMUNOLOGY

Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer

(2014) N Hasima et al.   Cell Death & Disease

Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop

(2014) Shravanti Mukherjee et al.   Stem Cell Research & Therapy

Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling

(2013) Yingzhuan Zhan et al.   ARCHIVES OF PHARMACAL RESEARCH

Molecular mechanisms of curcumin action: Signal transduction

(2013) Adeeb Shehzad et al.   BIOFACTORS

FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells

(2013) Dewan Md Sakib Hossain et al.   IMMUNITY

Gold nanostars for superficial diseases: a promising tool for localized hyperthermia?

(2013) Giuseppe Chirico et al.   Nanomedicine

The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature

(2012) R. J. deLeeuw et al.   CLINICAL CANCER RESEARCH

Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro

(2012) Guang-ju Zhao et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Advances in nanotechnology-based delivery systems for curcumin

(2012) Min Sun et al.   Nanomedicine

Natural Innate and Adaptive Immunity to Cancer

(2011) Matthew D. Vesely et al.   Annual Review of Immunology

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival

(2011) Jonathan R. Brody et al.   CELL CYCLE

Association of galectin-3 expression with melanoma progression and prognosis

(2011) Ewan R. Brown et al.   EUROPEAN JOURNAL OF CANCER

Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity

(2011) Feifei Luo et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer

(2011) Gouri Sankar Sen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MART-1- and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In Vitro

(2011) Mariana Aris et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence

(2011) Eijun Itakura et al.   MODERN PATHOLOGY

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

(2011) Reason Wilken et al.   Molecular Cancer

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized

(2010) Elsa Quintana et al.   CANCER CELL

Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts

(2010) Sankar Bhattacharyya et al.   Cellular & Molecular Immunology

Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells

(2010) Juni Chakraborty et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?

(2009) Jayaraj Ravindran et al.   AAPS Journal

Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT

(2009) Ji Hoon Lee et al.   CANCER LETTERS

GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells

(2009) G. Sa et al.   CANCER RESEARCH

Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells

(2009) Jin-bo Wang et al.   Journal of Zhejiang University-SCIENCE B

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

(2008) Simone Reuter et al.   BIOCHEMICAL PHARMACOLOGY

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

(2008) Preetha Anand et al.   BIOCHEMICAL PHARMACOLOGY

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

(2008) Ajaikumar B. Kunnumakkara et al.   CANCER LETTERS

Immunomodulatory effects of curcumin: In-vivo

(2008) Ch. Varalakshmi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

(2008) Bharat B. Aggarwal et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Anti cancer effects of curcumin: cycle of life and death

(2008) Gaurisankar Sa et al.   Cell Division